An email has been sent to your address with instructions for changing your password.
There is no user registered with this email.
Sign Up
To create a free account, please fill out the form below.
Thank you for signing up!
A confirmation email has been sent to your email address. Please check your email and follow the instructions in the message to complete the registration process. If you do not receive the email, please check your spam folder or contact us for assistance.
Welcome to our platform!
Oops!
Something went wrong while trying to create your new account. Please try again and if the problem persist, Email Us to receive support.
AstraZeneca Awards 30 Nonprofit Organizations through the ACT on Health Equity Community Solutions Challenge to Actively Address Health Disparities
Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Positive)
Tags
Rhea-AI Summary
AstraZeneca has launched the ACT on Health Equity: Community Solutions Challenge, contributing funds to 30 nonprofit organizations across the US. This initiative aims to enhance health equity by supporting underserved populations. Over 1,350 applications were received in its inaugural year, reflecting a wide interest in community health and youth education. The challenge aligns with AstraZeneca's long-term commitment to health equity and is supported by experts in the field. Programs funded will employ community-based approaches to improve local health outcomes.
Positive
AstraZeneca allocated funds to 30 nonprofits focusing on health equity.
The initiative attracted over 1,350 applications, indicating strong community engagement.
Negative
None.
In its inaugural year, this challenge demonstrates one part of AstraZeneca’s long-term commitment to identify and invest in solutions to advance health equity in partnership with the external community
Recipient organizations from all across the country will deliver programs that take a community-based approach to improve local health outcomes
WILMINGTON, Del.--(BUSINESS WIRE)--
AstraZeneca is proud to announce contributions to 30 nonprofit, community-based organizations nationwide through the ACT on Health Equity: Community Solutions Challenge. Recipients will use the funds to accelerate positive change for underserved populations at the local level.
“AstraZeneca is committed to advancing health equity in the US and we realize that this can only be done in partnership with local community leaders. The Community Solutions Challenge is a deliberate addition to our giving strategy which we believe is fundamental to achieving greater impact. We must work together at the community level in our schools, homes and communities to address the factors that contribute to inequities,” said Martha Orzechowski, Head, US Advocacy & Alliance, Corporate Affairs. “This distinguished group of organizations is leading change and making a direct, positive impact on underserved populations in all regions of the country.”
The AstraZeneca ACT on Health Equity: Community Solutions Challenge is part of Accelerate Change Together on Health Equity, AstraZeneca’s long-term commitment to identify and invest in solutions to advance health equity in partnership with the external community. Applicants were invited to apply under two focuses—Community Health and Wellbeing or Youth STEM Education and Career Readiness. In its inaugural year, more than 1,350 applications were received representing 49 US states. ACT on Health Equity is informed by the AstraZeneca Health Equity Advisory Council, a distinguished group of national experts and is committed to making an impact on the health and wellbeing of all people.
“The COVID-19 pandemic is a wake-up call from Mother Nature; misinformation is real, trust matters and the health promotion message must be culturally matched with the right messenger. By working together today, we can make a better tomorrow - where science will help ensure everyone has a chance to be as healthy as possible,” said Dr. Stephen B. Thomas, member of the AstraZeneca Health Equity Advisory Council, professor and Director of the Center for Health Equity at the University of Maryland School of Public Health in College Park, MD.
Recipient organizations are taking innovative and tailored approaches to improve outcomes for their communities - from ensuring science comes to life for public school students in New Mexico, to providing support for Burmese immigrants in Indiana. Below is a regional snapshot of the nonprofit organizations awarded. For more information, please visit the AstraZeneca US blog.
Northeast
Community Servings, Inc. – Massachusetts YOU, Inc. – Worcester, Massachusetts
Mid-Atlantic After-School All-Stars – Philadelphia, Pennsylvania and Camden, New Jersey Big Picture Philadelphia – Philadelphia, Pennsylvania Delaware Breast Cancer Coalition – Delaware Esperanza – Philadelphia, Pennsylvania Genesys Works – New York City, New York Kid Power, Inc. – Washington, District of Columbia Luminis Health Anne Arundel Medical Center – Anne Arundel and Prince George’s Counties, Maryland The Academy of Natural Sciences of Drexel University – Philadelphia, Pennsylvania The Police Athletic League – New York, New York The Upstate Foundation – Syracuse, New York Towson University Foundation, Inc. – Maryland YWCA Tri County Area – Pottstown, Pennsylvania
South
Coastal Bend Wellness Foundation – San Antonio, Texas Code/Art – South Florida Eva’s Heroes – Texas Florida Justice Center – Broward and Miami-Dade Counties, Florida Public Health Institute – Albuquerque, New Mexico Santa Fe Alliance for Science – Santa Fe, New Mexico
Midwest
Femergy – Central Ohio Franciscan Health Foundation – Southern Indianapolis LAHC - Leaders Advancing & Helping Communities – Dearborn, Michigan Medical Organization for Latino Advancement – Illinois Partnership for Innovation in Education – Ohio Saint Anthony Hospital – West and Southside Chicago, Illinois
West
Adolescent Counseling Services – Santa Clara and San Mateo, California Montana State University Foundation – Montana Multiplier - Nest for Families – Hawaii New Village Girls Academy – Los Angeles, California
About AstraZeneca
AstraZeneca is a global, science-led biopharmaceutical company that focuses on the discovery, development and commercialization of prescription medicines in Oncology, Rare Diseases and BioPharmaceuticals, including Cardiovascular, Renal & Metabolism, and Respiratory & Immunology. Based in Cambridge, UK, AstraZeneca operates in over 100 countries, and its innovative medicines are used by millions of patients worldwide. For more information, please visit www.astrazeneca-us.com and follow us on Twitter @AstraZenecaUS.